Close
Help




JOURNAL

Biomarkers in Cancer

Biomarkers of HIV-associated Cancer

Submit a Paper


Biomarkers in Cancer 2014:6 11-20

Review

Published on 03 Jul 2014

DOI: 10.4137/BIC.S15056


Further metadata provided in PDF



Sign up for email alerts to receive notifications of new articles published in Biomarkers in Cancer

Abstract

Cancer biomarkers have provided great opportunities for improving the management of cancer patients by enhancing the efficiency of early detection, diagnosis, and efficacy of treatment. Every cell type has a unique molecular signature, referred to as biomarkers, which are identifiable characteristics such as levels or activities of a myriad of genes, proteins, or other molecular features. Biomarkers can facilitate the molecular definition of cancer, provide information about the course of cancer, and predict response to chemotherapy. They offer the hope of early detection as well as tracking disease progression and recurrence. Current progress in the characterization of molecular genetics of HIV-associated cancers may form the basis for improved patient stratification and future targeted or individualized therapies. Biomarker use for cancer staging and personalization of therapy at the time of diagnosis could improve patient care. This review focuses on the relevance of biomarkers in the most common HIV-associated malignancies, namely, Kaposi sarcoma, non-Hodgkin’s lymphoma, and invasive cervical cancer.



Downloads

PDF  (839.70 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML




What Your Colleagues Say About Biomarkers in Cancer
The editorial staff of Biomarkers in Cancer are very efficient and helpful.  I am happy to work with them.  I look forward to reviewing future manuscripts.
Dr Xi Liu (National Cancer Institute, National Institutes of Health, Bethesda, MD, USA )
More Testimonials

Quick Links


New article and journal news notification services